14.27
price up icon5.16%   0.70
after-market Handel nachbörslich: 14.25 -0.02 -0.14%
loading

Stoke Therapeutics Inc Aktie (STOK) Neueste Nachrichten

pulisher
01:07 AM

Biogen Inc. (BIIB) Partners with Stoke Therapeutics to Tackle Dravet Syndrome - MSN

01:07 AM
pulisher
07:05 AM

Stoke Therapeutics Soars 17.02% on Market Optimism - AInvest

07:05 AM
pulisher
12:23 PM

What drives Stoke Therapeutics Inc. stock priceRobust investment performance - jammulinksnews.com

12:23 PM
pulisher
Jul 22, 2025

Stoke Therapeutics Inc. Stock Analysis and ForecastFree Investment Case Studies - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

What analysts say about Stoke Therapeutics Inc. stockRapid growth opportunities - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Why Stoke Therapeutics Inc. stock attracts strong analyst attentionProven Return Strategy Execution - Newser

Jul 22, 2025
pulisher
Jul 22, 2025

Published on: 2025-07-22 13:02:52 - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 21, 2025

Is Stoke Therapeutics Inc. a good long term investmentExceptional profit velocity - PrintWeekIndia

Jul 21, 2025
pulisher
Jul 20, 2025

Jefferies Financial Group Begins Coverage on Stoke Therapeutics (NASDAQ:STOK) - Defense World

Jul 20, 2025
pulisher
Jul 20, 2025

How to Take Advantage of moves in (STOK) - news.stocktradersdaily.com

Jul 20, 2025
pulisher
Jul 19, 2025

Is Stoke Therapeutics, Inc.'s (NASDAQ:STOK) Recent Stock Performance Influenced By Its Fundamentals In Any Way? - 富途牛牛

Jul 19, 2025
pulisher
Jul 19, 2025

Stoke Therapeutics, Inc.'s (NASDAQ:STOK) Stock On An Uptrend: Could Fundamentals Be Driving The Momentum? - simplywall.st

Jul 19, 2025
pulisher
Jul 19, 2025

Stoke Therapeutics (STOK): A High-Conviction Buy with Disease-Modifying Potential in Dravet Syndrome - AInvest

Jul 19, 2025
pulisher
Jul 18, 2025

Jefferies Recommends Stoke Therapeutics (STOK) with a Buy Rating - GuruFocus

Jul 18, 2025
pulisher
Jul 18, 2025

Jefferies initiates Stoke Therapeutics stock with Buy rating on epilepsy drug potential - Investing.com Canada

Jul 18, 2025
pulisher
Jul 18, 2025

Published on: 2025-07-18 11:35:29 - jammulinksnews.com

Jul 18, 2025
pulisher
Jul 17, 2025

Stoke Therapeutics’ EMPEROR Study: A New Hope for Dravet Syndrome - TipRanks

Jul 17, 2025
pulisher
Jul 17, 2025

Stoke Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)July 16, 2025 - BioSpace

Jul 17, 2025
pulisher
Jul 16, 2025

Analysts Are Bullish on Top Healthcare Stocks: Eli Lilly & Co (LLY), Stoke Therapeutics (STOK) - The Globe and Mail

Jul 16, 2025
pulisher
Jul 15, 2025

How Stoke Therapeutics Inc. stock performs during market volatilityProven Trading Plan - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

What makes Stoke Therapeutics Inc. stock price move sharplyDaily Price Surge List - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Stoke Therapeutics (NASDAQ:STOK) investors are sitting on a loss of 58% if they invested five years ago - Yahoo Finance

Jul 15, 2025
pulisher
Jul 12, 2025

Canaccord Genuity Keeps Their Buy Rating on Stoke Therapeutics (STOK) - The Globe and Mail

Jul 12, 2025
$22.87
price up icon 4.91%
$36.01
price down icon 0.25%
$103.44
price up icon 0.51%
$28.01
price up icon 5.54%
$114.60
price up icon 2.84%
biotechnology ONC
$294.83
price down icon 0.26%
Kapitalisierung:     |  Volumen (24h):